LIYENNI GONZALEZ: Open Payments
NPI 1194332098 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 58 payments from 17 companies in 2025. Trend: 2023 $1,711 · 2024 $1,404 · 2025 $1,244
Food & beverage: $1,244
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $195 |
| Novo Nordisk Inc | 7 | $177 |
| PFIZER INC. | 5 | $122 |
| ABBVIE INC. | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Amgen Inc. | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Boston Scientific Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $61 |
Products named: ELIQUIS, Kerendia, LEQVIO, FARXIGA, Ozempic, VRAYLAR, General - Therapies, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
